Posttransplant lymphoproliferative disease in pediatric liver transplantation : Interplay between primary Epstein-Barr virus infection and immunosuppression

The incidence, risk factors, and outcome of posttransplant lymphoproliferative disease (PTLD) were examined for 298 children undergoing liver transplantation. The overall incidence of PTLD was 8.4% (25 of 298). Intensity of immunosuppression was found to be a major risk factor for the development of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 1996-08, Vol.62 (3), p.370-375
Hauptverfasser:	NEWELL, K. A, ALONSO, E. M, RUBIN, C. M, THISTLETHWAITE, J. R, WHITINGTON, P. F, BRUCE, D. S, MILLILS, J. M, PIPER, J. B, WOODLE, E. S, KELLY, S. M, KOEPPEN, H, HART, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Biological and medical sciences Child Child, Preschool Epstein-Barr virus Herpesvirus 4, Human Humans Immunosuppression - adverse effects Immunosuppressive Agents - therapeutic use Liver Transplantation Liver, biliary tract, pancreas, portal circulation, spleen Lymphoproliferative Disorders - etiology Lymphoproliferative Disorders - therapy Medical sciences Muromonab-CD3 - therapeutic use Postoperative Complications Reoperation Risk Factors Salvage Therapy Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the digestive system Survival Analysis Tacrolimus - therapeutic use Treatment Outcome Tumor Virus Infections - complications
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!